Literature DB >> 16580095

Validation of clinical criteria for possible vascular dementia in the oldest-old.

Jean-Pierre Bacchetta1, Enikö Kövari, Marco Merlo, Alessandra Canuto, François R Herrmann, Constantin Bouras, Gabriel Gold, Patrick R Hof, Panteleimon Giannakopoulos.   

Abstract

Although vascular dementia (VaD) is a main pathology in nonagenarians and centenarians, the validity of clinical criteria for this diagnosis is unknown. We analyzed 110 autopsy cases and reported sensitivities and specificities of the State of California Alzheimer's Disease Diagnostic and Treatment Centers (ADDTC) and National Institute for Neurological Disorders and Stroke (NINDS-AIREN) criteria for possible VaD as well as Hachinski ischemic score (HIS). Among them, there were 36 neuropathologically confirmed VaD cases. All criteria displayed comparable sensitivities (0.56-0.58). Specificities values were 0.74, 0.73 and 0.66, respectively. There was an age-related decrease on ADDTC criteria sensitivity due to the fact that 42% of pure VaD cases did not present with stroke. Thirty percent of mixed dementia (MD) cases were diagnosed as VaD by both NINDS-AIREN and ADDTC criteria. This proportion reached 45.9% for the HIS. These data demonstrate that the new diagnostic criteria for possible VaD do not provide a substantial gain of sensitivity compared to the HIS. Although their specificity was significantly lower in this age group compared to younger cohorts, all of them successfully exclude AD cases.

Entities:  

Mesh:

Year:  2006        PMID: 16580095     DOI: 10.1016/j.neurobiolaging.2006.02.006

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  6 in total

1.  Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

Authors:  T M Polvikoski; E C W van Straaten; F Barkhof; R Sulkava; H J Aronen; L Niinistö; M Oinas; P Scheltens; T Erkinjuntti; R N Kalaria
Journal:  Neurology       Date:  2010-11-03       Impact factor: 9.910

Review 2.  Diagnosis and management of vascular cognitive impairment.

Authors:  David L Nyenhuis; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2007-10       Impact factor: 5.113

3.  Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.

Authors:  Jon B Toledo; Steven E Arnold; Kevin Raible; Johannes Brettschneider; Sharon X Xie; Murray Grossman; Sarah E Monsell; Walter A Kukull; John Q Trojanowski
Journal:  Brain       Date:  2013-07-10       Impact factor: 13.501

Review 4.  Post-mortem assessment in vascular dementia: advances and aspirations.

Authors:  Kirsty E McAleese; Irina Alafuzoff; Andreas Charidimou; Jacques De Reuck; Lea T Grinberg; Atticus H Hainsworth; Tibor Hortobagyi; Paul Ince; Kurt Jellinger; Jing Gao; Raj N Kalaria; Gabor G Kovacs; Enikö Kövari; Seth Love; Mara Popovic; Olivia Skrobot; Ricardo Taipa; Dietmar R Thal; David Werring; Stephen B Wharton; Johannes Attems
Journal:  BMC Med       Date:  2016-08-26       Impact factor: 8.775

5.  Pathology and pathogenesis of vascular cognitive impairment-a critical update.

Authors:  Kurt A Jellinger
Journal:  Front Aging Neurosci       Date:  2013-04-10       Impact factor: 5.750

6.  Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.

Authors:  Dixon Yang; Arjun V Masurkar
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jan-Mar 01       Impact factor: 2.357

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.